ADC Therapeutics (ADCT) Cash from Investing Activities: 2018-2024
Historic Cash from Investing Activities for ADC Therapeutics (ADCT) over the last 7 years, with Dec 2024 value amounting to -$867,000.
- ADC Therapeutics' Cash from Investing Activities rose 52.24% to -$327,000 in Q4 2023 from the same period last year, while for Dec 2023 it was -$3.2 million, marking a year-over-year decrease of 368.12%. This contributed to the annual value of -$867,000 for FY2024, which is 73.04% up from last year.
- Latest data reveals that ADC Therapeutics reported Cash from Investing Activities of -$867,000 as of FY2024, which was up 73.04% from -$3.2 million recorded in FY2023.
- In the past 5 years, ADC Therapeutics' Cash from Investing Activities registered a high of -$687,000 during FY2022, and its lowest value of -$6.7 million during FY2021.
- For the 3-year period, ADC Therapeutics' Cash from Investing Activities averaged around -$1.6 million, with its median value being -$867,000 (2024).
- Per our database at Business Quant, ADC Therapeutics' Cash from Investing Activities skyrocketed by 89.70% in 2022 and then slumped by 368.12% in 2023.
- Over the past 5 years, ADC Therapeutics' Cash from Investing Activities (Yearly) stood at -$2.8 million in 2020, then plummeted by 135.96% to -$6.7 million in 2021, then soared by 89.70% to -$687,000 in 2022, then slumped by 368.12% to -$3.2 million in 2023, then skyrocketed by 73.04% to -$867,000 in 2024.